Virpax Pharmaceuticals, Inc. (55) | Human Resources (11)

Browse by Subcategory

Recent Contracts

Amendment No. 1, dated March 29, 2022, to the Employment Agreement by and between Virpax Pharmaceuticals, Inc. and Anthony Mack, dated September 18, 2017 (Filed With SEC on March 31, 2022)
First Amendment to the Amended and restated Virpax Pharmaceuticals, Inc. 2017 Equity Incentive Plan, dated April 25, 2020 (Filed With SEC on August 10, 2021)
Consulting Agreement by and between Virpax Pharmaceuticals, Inc. and Gerald Bruce, dated as of March 11, 2020 (Filed With SEC on October 9, 2020)
Amendment No. 1, dated March 29, 2022, to the Employment Agreement by and between Virpax Pharmaceuticals, Inc. and Christopher M. Chipman, dated April 7, 2021 (Filed With SEC on March 31, 2022)
Amendment No. 1, dated March 29, 2022, to the Employment Agreement by and between Virpax Pharmaceuticals, Inc. and Jeffrey Gudin, MD, dated April 15, 2021 (Filed With SEC on March 31, 2022)
Gudin Employment Agreement (Filed With SEC on April 19, 2021)
Chipman Employment Agreement (Filed With SEC on April 13, 2021)
Virpax Pharmaceuticals, Inc. 2017 Equity Incentive Plan (Filed With SEC on October 9, 2020)
Form of Nonqualified Stock Option Award under 2017 Equity Incentive Plan (Filed With SEC on October 9, 2020)
Form of Incentive Stock Option Award under 2017 Equity Incentive Plan (Filed With SEC on October 9, 2020)
Employment Agreement by and between Virpax Pharmaceuticals, Inc. and Anthony Mack, dated as of September 18, 2018 (Filed With SEC on October 9, 2020)